Multiple myeloma and immune thrombocytopenia

Clinical and Laboratory Haematology

Volumn 22, Issue 4, 2000, Pages 239-242

  Gupta, V ^a   Hegde, U M ^a,c   Parameswaran, R ^b   Newland, A C ^b  

^a EALING HOSPITAL   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

^c EALING HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

Immune thrombocytopenia; IVIg; Multiple myeloma; Splenectomy

Indexed keywords

ADULT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; EPISTAXIS; HUMAN; LYMPHOPROLIFERATIVE DISEASE; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 0033787120     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2257.2000.00125.x     Document Type: Article

References (11)

1. Shortened platelet half-life in multiple myeloma
2. Risk of pneumococcal septicemia in patients with chronic lymphoproliferative malignancies
3. The relative incidence of idiopathic and secondary autoimmune thrombocytopenia: A clinical and serological evaluation in 508 patients
4. Mechanisms of thrombocytopenia in patients with lymphoproliferative diseases
5. Autoimmune thrombocytopenic purpura complicating lymphoproliferative disorders
6. VAD chemotherapy for refractory multiple myeloma
7. Correlation between serum IgG, platelet membrane IgG and platelet function in hypergammaglobulinemia states
8. Clinical use of intravenous immunoglobulin in blood disorders
9. Oral idarubicin with CCNU (lomustine) and dexamethasone in the treatment of refractory or relapsed multiple myeloma
10. Multiple myeloma associated with immune thrombocytopenic purpura
11. Mechanism of intravenous immunoglobulin therapy in antibody-mediated autoimmune diseases